**Background:** Keratoconus (KC) is a progressive corneal ectatic disease that typically emerges during puberty and progresses into the mid-30s, with unpredictable severity. The etiology is multifactorial, and hormone imbalances have been increasingly recognized as significant modulators. Previous work identified alterations in gonadotropins (FSH and LH) and their receptors in KC. This study aimed to investigate the effects of exogenous FSH and LH on the keratoconic stromal microenvironment using an established three-dimensional in vitro model.
**Methods:** Primary corneal fibroblasts from healthy subjects (HCFs) and KC patients (HKCs) were isolated and cultured. For 2D studies, cells were stimulated with FSH (2.5 or 10 mIU/mL) or LH (5 or 35 mIU/mL) for 48 hours. Cell proliferation was assessed via BrdU assay, and morphology was monitored. For 3D studies, cells were cultured on Transwell plates with stable vitamin C to promote extracellular matrix assembly and stimulated with FSH 10 mIU/mL or LH 5 mIU/mL for 4 weeks. Protein expression was evaluated by Western blot for sex hormone receptors (AR, PR, ERα, ERβ, GnRHR), fibrotic markers (EDA-Fn, α-SMA), proteoglycans (keratocan, lumican), and gonadotropin signaling pathway components (CRH, GPER, cAMP, pan-AKT, PKA, JNK, ERK 1/2, CREB, CYP3A4). Statistical analysis used one-way ANOVA with significance at P < 0.05.
**Key Results:** In 2D cultures, GnRHR expression was significantly higher in HKCs stimulated with FSH 2.5 mIU/mL compared to LH 35 mIU/mL (P = 0.0242). BrdU assay showed significantly greater proliferation in HKCs stimulated with LH 5 mIU/mL compared to HCFs (P = 0.0127), while FSH had no effect. In 3D cultures, LH 5 mIU/mL significantly up-regulated PR (P = 0.0259) and ERβ (P = 0.0356) in HCFs, and ERβ in HKCs (P = 0.0043) compared to controls. AR expression was significantly higher in HKCs versus HCFs with FSH 10 mIU/mL (P = 0.0259), while PR and ERα were significantly lower in HKCs versus HCFs with LH 5 mIU/mL (P = 0.0338 and P = 0.0431, respectively). Fibrosis markers: In HKCs, α-SMA was significantly down-regulated with both FSH 10 mIU/mL (P = 0.0197) and LH 5 mIU/mL (P = 0.0084), and EDA-Fn was down-regulated with LH 5 mIU/mL (P = 0.0150). Both EDA-Fn and α-SMA were significantly higher in LH-stimulated HCFs compared to HKCs (P = 0.042 and P = 0.015, respectively). Proteoglycans: Keratocan was significantly up-regulated in HCFs with LH 5 mIU/mL (P < 0.0001) and was higher in HCFs versus HKCs with both FSH and LH (P = 0.0283 and P < 0.0001). Lumican was significantly down-regulated with both FSH and LH in HCFs and HKCs (all P ≤ 0.0073). Signaling pathways: In HKCs, GPER was significantly up-regulated with LH 5 mIU/mL versus control (P = 0.0030) and versus FSH (P = 0.0026), and was higher than in HCFs with LH (P = 0.0067). PKA was significantly down-regulated in HKCs with LH 5 mIU/mL (P = 0.0350). Pan-AKT was up-regulated in HCFs with FSH 10 mIU/mL versus control (P = 0.0175) and versus LH (P = 0.0169). JNK was significantly lower in HKCs versus HCFs with FSH 10 mIU/mL (P = 0.0129). CREB was significantly higher in HKCs versus HCFs with LH 5 mIU/mL (P = 0.0342).
**Clinical Implications:** This study demonstrates that exogenous gonadotropins, particularly LH, selectively modulate the keratoconic stromal microenvironment by increasing proliferation and reducing fibrosis markers in KC cells, while FSH has minimal effects. The findings suggest that LH may play a protective role in KC, potentially through GPER signaling. These results highlight the importance of hormonal regulation in corneal homeostasis and KC pathogenesis. Further in vivo and clinical studies are warranted to validate these findings and explore therapeutic strategies targeting gonadotropin pathways in KC patients.